Immunization with Leishmania tarentolae-derived norovirus virus-like particles elicits high humoral response and stimulates the production of neutralizing antibodies

Multi-epitope vaccine expressed in Leishmania tarentolae confers protective immunity to Toxoplasma gondii in BALB/c mice

(2021) Hamidreza Majidiani et al.   MICROBIAL PATHOGENESIS

Leishmania mexicana recombinant filamentous acid phosphatase as carrier for Toxoplasma gondii surface antigen 1 expression in Leishmania tarentolae

(2021) Dalia Ahmed Kalef   Journal of Parasitic Diseases

Immunosensor Based on Long-Period Fiber Gratings for Detection of Viruses Causing Gastroenteritis

(2020) Marta Janczuk-Richter et al.   SENSORS

Expression, Purification, and Evaluation of Anti-IL-2Rα Antibody Secreted by Leishmania tarentolae

(2020) Akram Jalali et al.   International Journal of Peptide Research and Therapeutics

Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice

(2020) Samira Salari et al.   Parasites & Vectors

Norovirus Vaccine: Priorities for Future Research and Development

(2020) Susanna Esposito et al.   Frontiers in Immunology

GII.4 Human Norovirus: Surveying the Antigenic Landscape

(2019) Michael Mallory et al.   Viruses-Basel

Heterologous expression of the mammalian sodium-nucleobase transporter rSNBT1 in Leishmania tarentolae

(2019) Anargyros Doukas et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES

Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus than Sequential Immunization

(2019) Maria Malm et al.   Viruses-Basel

Major findings and recent advances in virus–like particle (VLP)-based vaccines

(2017) Mona O. Mohsen et al.   SEMINARS IN IMMUNOLOGY

Report from the World Health Organization’s third Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 8–10th June 2016

(2017) Birgitte K. Giersing et al.   VACCINE

Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus

(2016) Anna Czarnota et al.   Microbial Cell Factories

Rotavirus Recombinant VP6 Nanotubes Act as an Immunomodulator and Delivery Vehicle for Norovirus Virus-Like Particles

(2016) Maria Malm et al.   Journal of Immunology Research

VLP production in Leishmania tarentolae : A novel expression system for purification and assembly of HPV16 L1

(2015) Azam Bolhassani et al.   PROTEIN EXPRESSION AND PURIFICATION

A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice

(2015) Xiaoli Wang et al.   VACCINE

Expression of single-chain variable fragments fused with the Fc-region of rabbit IgG in Leishmania tarentolae

(2014) Mathias Jørgensen et al.   Microbial Cell Factories

Proposal for a unified norovirus nomenclature and genotyping

(2013) Annelies Kroneman et al.   ARCHIVES OF VIROLOGY

Epidemiology of human noroviruses and updates on vaccine development

(2013) Sasirekha Ramani et al.   CURRENT OPINION IN GASTROENTEROLOGY

Emergence of New Pandemic GII.4 Sydney Norovirus Strain Correlates With Escape From Herd Immunity

(2013) Kari Debbink et al.   JOURNAL OF INFECTIOUS DISEASES

Norovirus P Particle Efficiently Elicits Innate, Humoral and Cellular Immunity

(2013) Hao Fang et al.   PLoS One

Characterization and immunogenicity of norovirus capsid-derived virus-like particles purified by anion exchange chromatography

(2012) L. Huhti et al.   ARCHIVES OF VIROLOGY

Norovirus P particle: a subviral nanoparticle for vaccine development against norovirus, rotavirus and influenza virus

(2012) Ming Tan et al.   Nanomedicine

Immunogenicity and specificity of norovirus Consensus GII.4 virus-like particles in monovalent and bivalent vaccine formulations

(2012) Gabriel I. Parra et al.   VACCINE

Purification and crystallization of human Cu/Zn superoxide dismutase recombinantly produced in the protozoanLeishmania tarentolae

(2010) Emerich Mihai Gazdag et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

Virus-like particles in vaccine development

(2010) António Roldão et al.   Expert Review of Vaccines

Adjuvanted Intranasal Norwalk Virus‐Like Particle Vaccine Elicits Antibodies and Antibody‐Secreting Cells That Express Homing Receptors for Mucosal and Peripheral Lymphoid Tissues

(2010) Samer S. El‐Kamary et al.   JOURNAL OF INFECTIOUS DISEASES

Norovirus P Particle, a Novel Platform for Vaccine Development and Antibody Production

(2010) M. Tan et al.   JOURNAL OF VIROLOGY

A simple and rapid method for isolation of caliciviruses from liver of infected rabbits

(2010) Luzia Teixeira et al.   RESEARCH IN VETERINARY SCIENCE

Viral Inactivation in Foods: A Review of Traditional and Novel Food-Processing Technologies

(2009) Kirsten A. Hirneisen et al.   COMPREHENSIVE REVIEWS IN FOOD SCIENCE AND FOOD SAFETY

Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus Challenge

(2009) A. D. LoBue et al.   JOURNAL OF VIROLOGY

Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasis

(2009) Amir Mizbani et al.   VACCINE

Characterisation of a GII-4 norovirus variant-specific surface-exposed site involved in antibody binding

(2009) David J Allen et al.   Virology Journal